Those working in the pharmaceutical field often come across issues at the crossroads between IP and competition law. Our friends at Informa are organizing a 1-day event to discuss the latest developments in the field of competition law as applied to the pharmaceutical sector.
Held in Brussels on 4 December 2019, this 1-day conference will cover the latest market trends, policy and case law developments, as well as practical strategies to address the new challenges currently affecting the pharmaceutical sector across Europe.
Speakers include representatives of the European Commission, national regulators, in-house counsel and eminent lawyers from across the industry.
The other good news is that there is a special 15% IPKat discount for this event.
For more information and to register, click here and use the VIP code FKW82895IPKAT.
Do you want to reuse the IPKat content? Please refer to our
Policies section.
If you have any queries or requests for permission, please get in touch with the IPKat team.
Comments
Post a Comment
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html